Global Isocitrate Dehydrogenase Inhibitors Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Isocitrate Dehydrogenase Inhibitors market size was valued at US$ million in 2023. With growing demand in downstream market, the Isocitrate Dehydrogenase Inhibitors is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Isocitrate Dehydrogenase Inhibitors market. Isocitrate Dehydrogenase Inhibitors are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Isocitrate Dehydrogenase Inhibitors. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Isocitrate Dehydrogenase Inhibitors market.
Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (?-ketoglutarate) and CO2.
Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors including astrocytoma, oligodendroglioma and glioblastoma multiforme, with mutations found in nearly all cases of secondary glioblastomas, which develop from lower-grade gliomas, but rarely in primary high-grade glioblastoma multiforme.Patients whose tumor had an IDH1 mutation had longer survival. Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).These mutations are known to produce (D)-2-hydroxyglutarate from alpha-ketoglutarate.(D)-2-hydroxyglutarate accumulates to very high concentrations which inhibits the function of enzymes that are dependent on alpha-ketoglutarate.This leads to a hypermethylated state of DNA and histones, which results in different gene expression that can activate oncogenes and inactivate tumor-suppressor genes. Ultimately, this may lead to the types of cancer described above.Isocitrate dehydrogenase inhibition technology can be effectively applied to the cancer market.
Key Features:
The report on Isocitrate Dehydrogenase Inhibitors market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Isocitrate Dehydrogenase Inhibitors market. It may include historical data, market segmentation by Type (e.g., IDH1 Mutant Medullary Malignant Tumor, IDH2 Mutant Medullary Malignant Tumor), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Isocitrate Dehydrogenase Inhibitors market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Isocitrate Dehydrogenase Inhibitors market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Isocitrate Dehydrogenase Inhibitors industry. This include advancements in Isocitrate Dehydrogenase Inhibitors technology, Isocitrate Dehydrogenase Inhibitors new entrants, Isocitrate Dehydrogenase Inhibitors new investment, and other innovations that are shaping the future of Isocitrate Dehydrogenase Inhibitors.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Isocitrate Dehydrogenase Inhibitors market. It includes factors influencing customer ' purchasing decisions, preferences for Isocitrate Dehydrogenase Inhibitors product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Isocitrate Dehydrogenase Inhibitors market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Isocitrate Dehydrogenase Inhibitors market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Isocitrate Dehydrogenase Inhibitors market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Isocitrate Dehydrogenase Inhibitors industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Isocitrate Dehydrogenase Inhibitors market.
Market Segmentation:
Isocitrate Dehydrogenase Inhibitors market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Isocitrate Dehydrogenase Inhibitors market size was valued at US$ million in 2023. With growing demand in downstream market, the Isocitrate Dehydrogenase Inhibitors is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Isocitrate Dehydrogenase Inhibitors market. Isocitrate Dehydrogenase Inhibitors are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Isocitrate Dehydrogenase Inhibitors. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Isocitrate Dehydrogenase Inhibitors market.
Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (?-ketoglutarate) and CO2.
Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors including astrocytoma, oligodendroglioma and glioblastoma multiforme, with mutations found in nearly all cases of secondary glioblastomas, which develop from lower-grade gliomas, but rarely in primary high-grade glioblastoma multiforme.Patients whose tumor had an IDH1 mutation had longer survival. Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).These mutations are known to produce (D)-2-hydroxyglutarate from alpha-ketoglutarate.(D)-2-hydroxyglutarate accumulates to very high concentrations which inhibits the function of enzymes that are dependent on alpha-ketoglutarate.This leads to a hypermethylated state of DNA and histones, which results in different gene expression that can activate oncogenes and inactivate tumor-suppressor genes. Ultimately, this may lead to the types of cancer described above.Isocitrate dehydrogenase inhibition technology can be effectively applied to the cancer market.
Key Features:
The report on Isocitrate Dehydrogenase Inhibitors market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Isocitrate Dehydrogenase Inhibitors market. It may include historical data, market segmentation by Type (e.g., IDH1 Mutant Medullary Malignant Tumor, IDH2 Mutant Medullary Malignant Tumor), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Isocitrate Dehydrogenase Inhibitors market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Isocitrate Dehydrogenase Inhibitors market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Isocitrate Dehydrogenase Inhibitors industry. This include advancements in Isocitrate Dehydrogenase Inhibitors technology, Isocitrate Dehydrogenase Inhibitors new entrants, Isocitrate Dehydrogenase Inhibitors new investment, and other innovations that are shaping the future of Isocitrate Dehydrogenase Inhibitors.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Isocitrate Dehydrogenase Inhibitors market. It includes factors influencing customer ' purchasing decisions, preferences for Isocitrate Dehydrogenase Inhibitors product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Isocitrate Dehydrogenase Inhibitors market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Isocitrate Dehydrogenase Inhibitors market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Isocitrate Dehydrogenase Inhibitors market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Isocitrate Dehydrogenase Inhibitors industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Isocitrate Dehydrogenase Inhibitors market.
Market Segmentation:
Isocitrate Dehydrogenase Inhibitors market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- IDH1 Mutant Medullary Malignant Tumor
- IDH2 Mutant Medullary Malignant Tumor
- Others
- DH Inhibitor
- FLT3 Inhibitor
- Hedgehog Pathway Inhibitor
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AGIOS
- Aslan Pharmaceuticals
- Bayer
- Beigene
- Bristol-Myers Squibb
- Celgene
- Daiichi Sankyo
- Philogen S.p.A.
- Tesaro
- Tragara/Adastra
- Tocagen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Isocitrate Dehydrogenase Inhibitors Market Size 2019-2030
2.1.2 Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Isocitrate Dehydrogenase Inhibitors Segment by Type
2.2.1 IDH1 Mutant Medullary Malignant Tumor
2.2.2 IDH2 Mutant Medullary Malignant Tumor
2.2.3 Others
2.3 Isocitrate Dehydrogenase Inhibitors Market Size by Type
2.3.1 Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
2.4 Isocitrate Dehydrogenase Inhibitors Segment by Application
2.4.1 DH Inhibitor
2.4.2 FLT3 Inhibitor
2.4.3 Hedgehog Pathway Inhibitor
2.4.4 Others
2.5 Isocitrate Dehydrogenase Inhibitors Market Size by Application
2.5.1 Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
3 ISOCITRATE DEHYDROGENASE INHIBITORS MARKET SIZE BY PLAYER
3.1 Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Players
3.1.1 Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2019-2024)
3.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Isocitrate Dehydrogenase Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ISOCITRATE DEHYDROGENASE INHIBITORS BY REGIONS
4.1 Isocitrate Dehydrogenase Inhibitors Market Size by Regions (2019-2024)
4.2 Americas Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
4.3 APAC Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
4.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
4.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024)
5.2 Americas Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
5.3 Americas Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024)
6.2 APAC Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
6.3 APAC Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Isocitrate Dehydrogenase Inhibitors by Country (2019-2024)
7.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors by Region (2019-2024)
8.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
8.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ISOCITRATE DEHYDROGENASE INHIBITORS MARKET FORECAST
10.1 Global Isocitrate Dehydrogenase Inhibitors Forecast by Regions (2025-2030)
10.1.1 Global Isocitrate Dehydrogenase Inhibitors Forecast by Regions (2025-2030)
10.1.2 Americas Isocitrate Dehydrogenase Inhibitors Forecast
10.1.3 APAC Isocitrate Dehydrogenase Inhibitors Forecast
10.1.4 Europe Isocitrate Dehydrogenase Inhibitors Forecast
10.1.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Forecast
10.2 Americas Isocitrate Dehydrogenase Inhibitors Forecast by Country (2025-2030)
10.2.1 United States Isocitrate Dehydrogenase Inhibitors Market Forecast
10.2.2 Canada Isocitrate Dehydrogenase Inhibitors Market Forecast
10.2.3 Mexico Isocitrate Dehydrogenase Inhibitors Market Forecast
10.2.4 Brazil Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3 APAC Isocitrate Dehydrogenase Inhibitors Forecast by Region (2025-2030)
10.3.1 China Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.2 Japan Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.3 Korea Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.4 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.5 India Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.6 Australia Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4 Europe Isocitrate Dehydrogenase Inhibitors Forecast by Country (2025-2030)
10.4.1 Germany Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.2 France Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.3 UK Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.4 Italy Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.5 Russia Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Forecast by Region (2025-2030)
10.5.1 Egypt Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.2 South Africa Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.3 Israel Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.4 Turkey Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.5 GCC Countries Isocitrate Dehydrogenase Inhibitors Market Forecast
10.6 Global Isocitrate Dehydrogenase Inhibitors Forecast by Type (2025-2030)
10.7 Global Isocitrate Dehydrogenase Inhibitors Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AGIOS
11.1.1 AGIOS Company Information
11.1.2 AGIOS Isocitrate Dehydrogenase Inhibitors Product Offered
11.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AGIOS Main Business Overview
11.1.5 AGIOS Latest Developments
11.2 Aslan Pharmaceuticals
11.2.1 Aslan Pharmaceuticals Company Information
11.2.2 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product Offered
11.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Aslan Pharmaceuticals Main Business Overview
11.2.5 Aslan Pharmaceuticals Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Isocitrate Dehydrogenase Inhibitors Product Offered
11.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Beigene
11.4.1 Beigene Company Information
11.4.2 Beigene Isocitrate Dehydrogenase Inhibitors Product Offered
11.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Beigene Main Business Overview
11.4.5 Beigene Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product Offered
11.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Celgene
11.6.1 Celgene Company Information
11.6.2 Celgene Isocitrate Dehydrogenase Inhibitors Product Offered
11.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgene Main Business Overview
11.6.5 Celgene Latest Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Information
11.7.2 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product Offered
11.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Daiichi Sankyo Main Business Overview
11.7.5 Daiichi Sankyo Latest Developments
11.8 Philogen S.p.A.
11.8.1 Philogen S.p.A. Company Information
11.8.2 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product Offered
11.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Philogen S.p.A. Main Business Overview
11.8.5 Philogen S.p.A. Latest Developments
11.9 Tesaro
11.9.1 Tesaro Company Information
11.9.2 Tesaro Isocitrate Dehydrogenase Inhibitors Product Offered
11.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Tesaro Main Business Overview
11.9.5 Tesaro Latest Developments
11.10 Tragara/Adastra
11.10.1 Tragara/Adastra Company Information
11.10.2 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product Offered
11.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Tragara/Adastra Main Business Overview
11.10.5 Tragara/Adastra Latest Developments
11.11 Tocagen
11.11.1 Tocagen Company Information
11.11.2 Tocagen Isocitrate Dehydrogenase Inhibitors Product Offered
11.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Tocagen Main Business Overview
11.11.5 Tocagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Isocitrate Dehydrogenase Inhibitors Market Size 2019-2030
2.1.2 Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Isocitrate Dehydrogenase Inhibitors Segment by Type
2.2.1 IDH1 Mutant Medullary Malignant Tumor
2.2.2 IDH2 Mutant Medullary Malignant Tumor
2.2.3 Others
2.3 Isocitrate Dehydrogenase Inhibitors Market Size by Type
2.3.1 Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
2.4 Isocitrate Dehydrogenase Inhibitors Segment by Application
2.4.1 DH Inhibitor
2.4.2 FLT3 Inhibitor
2.4.3 Hedgehog Pathway Inhibitor
2.4.4 Others
2.5 Isocitrate Dehydrogenase Inhibitors Market Size by Application
2.5.1 Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
3 ISOCITRATE DEHYDROGENASE INHIBITORS MARKET SIZE BY PLAYER
3.1 Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Players
3.1.1 Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2019-2024)
3.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Isocitrate Dehydrogenase Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ISOCITRATE DEHYDROGENASE INHIBITORS BY REGIONS
4.1 Isocitrate Dehydrogenase Inhibitors Market Size by Regions (2019-2024)
4.2 Americas Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
4.3 APAC Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
4.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
4.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024)
5.2 Americas Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
5.3 Americas Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024)
6.2 APAC Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
6.3 APAC Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Isocitrate Dehydrogenase Inhibitors by Country (2019-2024)
7.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors by Region (2019-2024)
8.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
8.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ISOCITRATE DEHYDROGENASE INHIBITORS MARKET FORECAST
10.1 Global Isocitrate Dehydrogenase Inhibitors Forecast by Regions (2025-2030)
10.1.1 Global Isocitrate Dehydrogenase Inhibitors Forecast by Regions (2025-2030)
10.1.2 Americas Isocitrate Dehydrogenase Inhibitors Forecast
10.1.3 APAC Isocitrate Dehydrogenase Inhibitors Forecast
10.1.4 Europe Isocitrate Dehydrogenase Inhibitors Forecast
10.1.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Forecast
10.2 Americas Isocitrate Dehydrogenase Inhibitors Forecast by Country (2025-2030)
10.2.1 United States Isocitrate Dehydrogenase Inhibitors Market Forecast
10.2.2 Canada Isocitrate Dehydrogenase Inhibitors Market Forecast
10.2.3 Mexico Isocitrate Dehydrogenase Inhibitors Market Forecast
10.2.4 Brazil Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3 APAC Isocitrate Dehydrogenase Inhibitors Forecast by Region (2025-2030)
10.3.1 China Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.2 Japan Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.3 Korea Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.4 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.5 India Isocitrate Dehydrogenase Inhibitors Market Forecast
10.3.6 Australia Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4 Europe Isocitrate Dehydrogenase Inhibitors Forecast by Country (2025-2030)
10.4.1 Germany Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.2 France Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.3 UK Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.4 Italy Isocitrate Dehydrogenase Inhibitors Market Forecast
10.4.5 Russia Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Forecast by Region (2025-2030)
10.5.1 Egypt Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.2 South Africa Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.3 Israel Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.4 Turkey Isocitrate Dehydrogenase Inhibitors Market Forecast
10.5.5 GCC Countries Isocitrate Dehydrogenase Inhibitors Market Forecast
10.6 Global Isocitrate Dehydrogenase Inhibitors Forecast by Type (2025-2030)
10.7 Global Isocitrate Dehydrogenase Inhibitors Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AGIOS
11.1.1 AGIOS Company Information
11.1.2 AGIOS Isocitrate Dehydrogenase Inhibitors Product Offered
11.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AGIOS Main Business Overview
11.1.5 AGIOS Latest Developments
11.2 Aslan Pharmaceuticals
11.2.1 Aslan Pharmaceuticals Company Information
11.2.2 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product Offered
11.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Aslan Pharmaceuticals Main Business Overview
11.2.5 Aslan Pharmaceuticals Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Isocitrate Dehydrogenase Inhibitors Product Offered
11.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Beigene
11.4.1 Beigene Company Information
11.4.2 Beigene Isocitrate Dehydrogenase Inhibitors Product Offered
11.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Beigene Main Business Overview
11.4.5 Beigene Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product Offered
11.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Celgene
11.6.1 Celgene Company Information
11.6.2 Celgene Isocitrate Dehydrogenase Inhibitors Product Offered
11.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgene Main Business Overview
11.6.5 Celgene Latest Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Information
11.7.2 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product Offered
11.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Daiichi Sankyo Main Business Overview
11.7.5 Daiichi Sankyo Latest Developments
11.8 Philogen S.p.A.
11.8.1 Philogen S.p.A. Company Information
11.8.2 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product Offered
11.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Philogen S.p.A. Main Business Overview
11.8.5 Philogen S.p.A. Latest Developments
11.9 Tesaro
11.9.1 Tesaro Company Information
11.9.2 Tesaro Isocitrate Dehydrogenase Inhibitors Product Offered
11.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Tesaro Main Business Overview
11.9.5 Tesaro Latest Developments
11.10 Tragara/Adastra
11.10.1 Tragara/Adastra Company Information
11.10.2 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product Offered
11.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Tragara/Adastra Main Business Overview
11.10.5 Tragara/Adastra Latest Developments
11.11 Tocagen
11.11.1 Tocagen Company Information
11.11.2 Tocagen Isocitrate Dehydrogenase Inhibitors Product Offered
11.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Tocagen Main Business Overview
11.11.5 Tocagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of IDH1 Mutant Medullary Malignant Tumor
Table 3. Major Players of IDH2 Mutant Medullary Malignant Tumor
Table 4. Major Players of Others
Table 5. Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 8. Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 11. Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Player (2019-2024)
Table 13. Isocitrate Dehydrogenase Inhibitors Key Players Head office and Products Offered
Table 14. Isocitrate Dehydrogenase Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Regions (2019-2024)
Table 19. Global Isocitrate Dehydrogenase Inhibitors Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Country (2019-2024)
Table 23. Americas Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 25. Americas Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 27. APAC Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region (2019-2024)
Table 29. APAC Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 31. APAC Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 33. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Country (2019-2024)
Table 35. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 37. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Isocitrate Dehydrogenase Inhibitors
Table 46. Key Market Challenges & Risks of Isocitrate Dehydrogenase Inhibitors
Table 47. Key Industry Trends of Isocitrate Dehydrogenase Inhibitors
Table 48. Global Isocitrate Dehydrogenase Inhibitors Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Isocitrate Dehydrogenase Inhibitors Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Isocitrate Dehydrogenase Inhibitors Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. AGIOS Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 53. AGIOS Isocitrate Dehydrogenase Inhibitors Product Offered
Table 54. AGIOS Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AGIOS Main Business
Table 56. AGIOS Latest Developments
Table 57. Aslan Pharmaceuticals Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 58. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product Offered
Table 59. Aslan Pharmaceuticals Main Business
Table 60. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Aslan Pharmaceuticals Latest Developments
Table 62. Bayer Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 63. Bayer Isocitrate Dehydrogenase Inhibitors Product Offered
Table 64. Bayer Main Business
Table 65. Bayer Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bayer Latest Developments
Table 67. Beigene Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 68. Beigene Isocitrate Dehydrogenase Inhibitors Product Offered
Table 69. Beigene Main Business
Table 70. Beigene Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Beigene Latest Developments
Table 72. Bristol-Myers Squibb Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 73. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product Offered
Table 74. Bristol-Myers Squibb Main Business
Table 75. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Bristol-Myers Squibb Latest Developments
Table 77. Celgene Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 78. Celgene Isocitrate Dehydrogenase Inhibitors Product Offered
Table 79. Celgene Main Business
Table 80. Celgene Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Celgene Latest Developments
Table 82. Daiichi Sankyo Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 83. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product Offered
Table 84. Daiichi Sankyo Main Business
Table 85. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Daiichi Sankyo Latest Developments
Table 87. Philogen S.p.A. Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 88. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product Offered
Table 89. Philogen S.p.A. Main Business
Table 90. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Philogen S.p.A. Latest Developments
Table 92. Tesaro Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 93. Tesaro Isocitrate Dehydrogenase Inhibitors Product Offered
Table 94. Tesaro Main Business
Table 95. Tesaro Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Tesaro Latest Developments
Table 97. Tragara/Adastra Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 98. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product Offered
Table 99. Tragara/Adastra Main Business
Table 100. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Tragara/Adastra Latest Developments
Table 102. Tocagen Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 103. Tocagen Isocitrate Dehydrogenase Inhibitors Product Offered
Table 104. Tocagen Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Tocagen Main Business
Table 106. Tocagen Latest Developments
Table 1. Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of IDH1 Mutant Medullary Malignant Tumor
Table 3. Major Players of IDH2 Mutant Medullary Malignant Tumor
Table 4. Major Players of Others
Table 5. Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 8. Isocitrate Dehydrogenase Inhibitors Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 11. Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Player (2019-2024)
Table 13. Isocitrate Dehydrogenase Inhibitors Key Players Head office and Products Offered
Table 14. Isocitrate Dehydrogenase Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Regions (2019-2024)
Table 19. Global Isocitrate Dehydrogenase Inhibitors Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Country (2019-2024)
Table 23. Americas Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 25. Americas Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 27. APAC Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region (2019-2024)
Table 29. APAC Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 31. APAC Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 33. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Country (2019-2024)
Table 35. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 37. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Isocitrate Dehydrogenase Inhibitors
Table 46. Key Market Challenges & Risks of Isocitrate Dehydrogenase Inhibitors
Table 47. Key Industry Trends of Isocitrate Dehydrogenase Inhibitors
Table 48. Global Isocitrate Dehydrogenase Inhibitors Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Isocitrate Dehydrogenase Inhibitors Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Isocitrate Dehydrogenase Inhibitors Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. AGIOS Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 53. AGIOS Isocitrate Dehydrogenase Inhibitors Product Offered
Table 54. AGIOS Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AGIOS Main Business
Table 56. AGIOS Latest Developments
Table 57. Aslan Pharmaceuticals Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 58. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product Offered
Table 59. Aslan Pharmaceuticals Main Business
Table 60. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Aslan Pharmaceuticals Latest Developments
Table 62. Bayer Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 63. Bayer Isocitrate Dehydrogenase Inhibitors Product Offered
Table 64. Bayer Main Business
Table 65. Bayer Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bayer Latest Developments
Table 67. Beigene Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 68. Beigene Isocitrate Dehydrogenase Inhibitors Product Offered
Table 69. Beigene Main Business
Table 70. Beigene Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Beigene Latest Developments
Table 72. Bristol-Myers Squibb Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 73. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product Offered
Table 74. Bristol-Myers Squibb Main Business
Table 75. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Bristol-Myers Squibb Latest Developments
Table 77. Celgene Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 78. Celgene Isocitrate Dehydrogenase Inhibitors Product Offered
Table 79. Celgene Main Business
Table 80. Celgene Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Celgene Latest Developments
Table 82. Daiichi Sankyo Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 83. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product Offered
Table 84. Daiichi Sankyo Main Business
Table 85. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Daiichi Sankyo Latest Developments
Table 87. Philogen S.p.A. Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 88. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product Offered
Table 89. Philogen S.p.A. Main Business
Table 90. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Philogen S.p.A. Latest Developments
Table 92. Tesaro Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 93. Tesaro Isocitrate Dehydrogenase Inhibitors Product Offered
Table 94. Tesaro Main Business
Table 95. Tesaro Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Tesaro Latest Developments
Table 97. Tragara/Adastra Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 98. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product Offered
Table 99. Tragara/Adastra Main Business
Table 100. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Tragara/Adastra Latest Developments
Table 102. Tocagen Details, Company Type, Isocitrate Dehydrogenase Inhibitors Area Served and Its Competitors
Table 103. Tocagen Isocitrate Dehydrogenase Inhibitors Product Offered
Table 104. Tocagen Isocitrate Dehydrogenase Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Tocagen Main Business
Table 106. Tocagen Latest Developments
LIST OF FIGURES
Figure 1. Isocitrate Dehydrogenase Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Isocitrate Dehydrogenase Inhibitors Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Isocitrate Dehydrogenase Inhibitors Sales Market Share by Country/Region (2023)
Figure 8. Isocitrate Dehydrogenase Inhibitors Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type in 2023
Figure 10. Isocitrate Dehydrogenase Inhibitors in DH Inhibitor
Figure 11. Global Isocitrate Dehydrogenase Inhibitors Market: DH Inhibitor (2019-2024) & ($ Millions)
Figure 12. Isocitrate Dehydrogenase Inhibitors in FLT3 Inhibitor
Figure 13. Global Isocitrate Dehydrogenase Inhibitors Market: FLT3 Inhibitor (2019-2024) & ($ Millions)
Figure 14. Isocitrate Dehydrogenase Inhibitors in Hedgehog Pathway Inhibitor
Figure 15. Global Isocitrate Dehydrogenase Inhibitors Market: Hedgehog Pathway Inhibitor (2019-2024) & ($ Millions)
Figure 16. Isocitrate Dehydrogenase Inhibitors in Others
Figure 17. Global Isocitrate Dehydrogenase Inhibitors Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application in 2023
Figure 19. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Player in 2023
Figure 20. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 22. APAC Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 23. Europe Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 25. Americas Isocitrate Dehydrogenase Inhibitors Value Market Share by Country in 2023
Figure 26. United States Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region in 2023
Figure 31. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type in 2023
Figure 32. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application in 2023
Figure 33. China Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Country in 2023
Figure 40. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Figure 41. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Figure 42. Germany Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 56. APAC Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 57. Europe Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 59. United States Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 60. Canada Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 63. China Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 64. Japan Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 65. Korea Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 67. India Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 68. Australia Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 69. Germany Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 70. France Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 71. UK Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 72. Italy Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 73. Russia Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 74. Spain Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 77. Israel Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 80. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Isocitrate Dehydrogenase Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Isocitrate Dehydrogenase Inhibitors Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Isocitrate Dehydrogenase Inhibitors Sales Market Share by Country/Region (2023)
Figure 8. Isocitrate Dehydrogenase Inhibitors Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type in 2023
Figure 10. Isocitrate Dehydrogenase Inhibitors in DH Inhibitor
Figure 11. Global Isocitrate Dehydrogenase Inhibitors Market: DH Inhibitor (2019-2024) & ($ Millions)
Figure 12. Isocitrate Dehydrogenase Inhibitors in FLT3 Inhibitor
Figure 13. Global Isocitrate Dehydrogenase Inhibitors Market: FLT3 Inhibitor (2019-2024) & ($ Millions)
Figure 14. Isocitrate Dehydrogenase Inhibitors in Hedgehog Pathway Inhibitor
Figure 15. Global Isocitrate Dehydrogenase Inhibitors Market: Hedgehog Pathway Inhibitor (2019-2024) & ($ Millions)
Figure 16. Isocitrate Dehydrogenase Inhibitors in Others
Figure 17. Global Isocitrate Dehydrogenase Inhibitors Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application in 2023
Figure 19. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Player in 2023
Figure 20. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 22. APAC Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 23. Europe Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size 2019-2024 ($ Millions)
Figure 25. Americas Isocitrate Dehydrogenase Inhibitors Value Market Share by Country in 2023
Figure 26. United States Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region in 2023
Figure 31. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type in 2023
Figure 32. APAC Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application in 2023
Figure 33. China Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Country in 2023
Figure 40. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Figure 41. Europe Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Figure 42. Germany Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Isocitrate Dehydrogenase Inhibitors Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 56. APAC Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 57. Europe Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 59. United States Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 60. Canada Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 63. China Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 64. Japan Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 65. Korea Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 67. India Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 68. Australia Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 69. Germany Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 70. France Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 71. UK Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 72. Italy Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 73. Russia Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 74. Spain Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 77. Israel Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Isocitrate Dehydrogenase Inhibitors Market Size 2025-2030 ($ Millions)
Figure 80. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Isocitrate Dehydrogenase Inhibitors Market Size Market Share Forecast by Application (2025-2030)
